Key statistics
As of last trade Perspective Therapeutics Inc (AAJ0:STU) traded at 10.00, -41.86% below its 52-week high of 17.20, set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.30 |
---|---|
High | 10.30 |
Low | 10.00 |
Bid | 9.85 |
Offer | 10.10 |
Previous close | 10.30 |
Average volume | 160.67 |
---|---|
Shares outstanding | 67.43m |
Free float | 53.66m |
P/E (TTM) | -- |
Market cap | 719.45m USD |
EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Announcements
- Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
- Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
- Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
- Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research
- Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research
- Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day
- Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine
- Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024
- Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma
More ▼